C. Barrie

550 total citations
8 papers, 289 citations indexed

About

C. Barrie is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, C. Barrie has authored 8 papers receiving a total of 289 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 1 paper in Molecular Biology. Recurrent topics in C. Barrie's work include Cancer Immunotherapy and Biomarkers (4 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers) and Lung Cancer Treatments and Mutations (2 papers). C. Barrie is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers) and Lung Cancer Treatments and Mutations (2 papers). C. Barrie collaborates with scholars based in United Kingdom, India and Singapore. C. Barrie's co-authors include George Mawer, Gus A. Baker, Rebekah Shallcross, Marta García‐Fiñana, John R. Beech, Alan Fryer, Rebecca Bromley, Morris J. Cohen, David W. Loring and Rachel Kneen and has published in prestigious journals such as Neurology, Annals of Oncology and European Journal of Cancer.

In The Last Decade

C. Barrie

8 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C. Barrie United Kingdom	5	156	124	122	65	55	8	289
Hannah Mandle United States	10	186 1.2×	163 1.3×	140 1.1×	11 0.2×	15 0.3×	19	254
Catherine Lefebvre France	8	32 0.2×	200 1.6×	12 0.1×	37 0.6×	33 0.6×	18	387
P Sampaolo Italy	10	259 1.7×	149 1.2×	193 1.6×	23 0.4×	70 1.3×	21	465
N. Toft Denmark	5	197 1.3×	265 2.1×	23 0.2×	61 0.9×	33 0.6×	7	332
Gabriella Casazza Italy	8	30 0.2×	35 0.3×	39 0.3×	46 0.7×	78 1.4×	22	216
Check Jh United States	12	121 0.8×	241 1.9×	19 0.2×	16 0.2×	35 0.6×	89	471
J H Check United States	12	94 0.6×	205 1.7×	15 0.1×	16 0.2×	37 0.7×	58	435
Abha Majumdar India	10	131 0.8×	194 1.6×	23 0.2×	8 0.1×	54 1.0×	32	402
Stephanie Licata United States	7	18 0.1×	45 0.4×	75 0.6×	110 1.7×	26 0.5×	14	284
Orkun Tan United States	11	54 0.3×	71 0.6×	35 0.3×	11 0.2×	39 0.7×	18	309

Countries citing papers authored by C. Barrie

Since Specialization

Citations

This map shows the geographic impact of C. Barrie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Barrie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Barrie more than expected).

Fields of papers citing papers by C. Barrie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Barrie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Barrie. The network helps show where C. Barrie may publish in the future.

Co-authorship network of co-authors of C. Barrie

This figure shows the co-authorship network connecting the top 25 collaborators of C. Barrie. A scholar is included among the top collaborators of C. Barrie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Barrie. C. Barrie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Stares, Mark, Mark Baxter, F. M. Ross, et al.. (2022). Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancer. ESMO Open. 7(2). 100445–100445. 44 indexed citations

2.

Stares, Mark, Fiona Thomson, Melanie Mackean, et al.. (2021). P57.07 The Scottish Immunotherapy Prognostic Score (SIPS) Predicts Response to First-Line Pembrolizumab for Metastatic Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 16(10). S1139–S1140. 1 indexed citations

3.

Stares, Mark, R. A. Patton, Gillian Knowles, et al.. (2020). A biobank analysis of prognostic biomarkers of the systemic inflammatory response in patients presenting with malignancy of undefined primary origin. European Journal of Cancer. 139. 1–9. 5 indexed citations

4.

Tufail, Adnan, T. Evans, Melanie Mackean, et al.. (2020). Detecting early weight loss in patients with advanced lung cancer. Lung Cancer. 139. S80–S80. 3 indexed citations

5.

Middleton, Gary, Kristian Brock, Yvonne Summers, et al.. (2018). Pembrolizumab in performance status 2 patients with non-small cell lung cancer (NSCLC): Results of the PePS2 trial. Annals of Oncology. 29. viii497–viii497. 19 indexed citations

6.

Baker, Gus A., Rebecca Bromley, Christopher P. Cheyne, et al.. (2014). IQ at 6 years after in utero exposure to antiepileptic drugs. Neurology. 84(4). 382–390. 166 indexed citations

7.

Tan, David S.P., Tzyvia Rye, C. Barrie, et al.. (2014). Beneficial Effect of Adjuvant Chemotherapy and Whole Abdominal or Pelvic Radiotherapy (Waprt) on Progression Free and Overall Survival Following Primary Surgery in Patients with Ovarian Clear Cell Carcinoma (Occc). Annals of Oncology. 25. iv306–iv306. 1 indexed citations

8.

Ironside, James W., J. E. Bell, Linda McCardle, et al.. (1996). . Cold Spring Harbor Symposia on Quantitative Biology. 61(1). 523–530. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact